Scott,
<...whether we're discussing HDII...or SEPR or MLNM or BTRN or VRTX. While the latter four are hyped extensively on SI, HDII remains unknown. I've found this fact often plays a role in the degree to which SI participants focus on the 'competition' area of the 10K - the hyped stocks have the competition discounted whereas in the ignored companies it is emphasized.>
Your point is probably well taken, but I would like to stay focused on HDII for the moment. (Actually, I own all five and have made several X on the latter four. Fact is I am a dedicated lurker on all of the usual SI BT threads.)
Boiler plate warnings aside, here is what concerns me on the competition front;
"In addition, we are aware of other companies that are developing products that measure arterial elasticity. A technology called the "Complior" has been developed in France and has been reported in the general medical literature to measure "arterial stiffness" (versus elasticity). Research in a number of centers continues, supported by the "Complior," although the status of commercial sales are unknown at this time. The "Complior" device is based on "pulse wave velocity" (while our Product provides analysis of pulse waveforms).
To the best of our knowledge, no products which measure both large and small artery elasticity have yet obtained either CE Mark or FDA clearances to market, and no other products being developed or being marketed appear capable of providing both large artery and small artery elasticity values. We are aware of six other firms that are developing products that attempt to measure vascular elasticity and which may be viewed as competitive alternatives. The six firms are International Medical Device Partners (Las Vegas, Nevada), ASULAB Research Labs of the SMH Group (Neuchatel, Switzerland), Pulse Metric, Inc. (San Diego, California), PWV Medical Ltd. (Sydney, Australia), Specaway Pty Ltd. (St. Pauls New South Wales, Sydney, Australia) and Novacor (Paris, France). One such firm has received FDA clearance to market a device which claims to evaluate a patient's general cardiovascular condition."
Add what strikes me as real competition to my failure, as an engineer, to identify anything about their product which could not be fairly readily and independently developed and I find it hard to get very excited.
"Our Product incorporates a patented and proprietary instrument and procedures which painlessly and non-invasively collects 30 seconds of blood pressure waveform data, automatically analyzes this data by means of an embedded computer and generates a CardioVascular Profile Report. All versions of our Product consist of four primary components: (a) a non-invasive arterial pulse pressure or waveform sensor placed over the radial artery at the wrist; (b) an upper-arm blood pressure cuff connected to an oscillometric blood pressure module; (c) an enclosure which contains a computer, a touch-screen display and other electronics and software programs; and (d) an external printer.
The CardioVascular Profile Report currently generated by the CR-2000 Research System presents the following parameters: a 1.5 Second Blood Pressure Waveform Graph, Body Surface Area (BSA), Body Mass Index (BMI), Systolic Blood Pressure (mmHg), Diastolic Blood Pressure (mmHg), Mean Arterial Pressure (mmHg), Pulse Pressure (mmHg), Pulse Rate (beats/minute), Estimated Cardiac Ejection Time (milli-seconds), Estimated Stroke Volume (ml/beat), Estimated Stroke Volume Index (ml/beat/m2), Estimated Cardiac Output (Liters/minute), Estimated Cardiac Index (L/min/m2), Large Artery Elasticity Index (ml/mmHg x 10), Small Artery Elasticity Index (ml/mmHg x100), Systemic Vascular Resistance (dynesosecocm-5), and Total Vascular Impedance (dynesosecocm-5)."
Are there any numbers available on the number of units sold as a function of time? The absence of such data is bothersome.
My comment on the C&H formation was a loose one, largely based on my vague recollection that the chart should continue up strongly once the handle is formed to fit the pattern perfectly. I may be totally off. In any case I share your hope that my misgivings in this regard are premature.
BTW, I rather like their business plan. (its the data stupid)
SMH
PS - My biggest position (until loading up on BTRN recnetly) is another obscure little so and so - TRIBY.
Ever hear of it. |
